Ark Surgical

Commercial-stage medical device company in the field of women`s health, with 2 FDA-cleared devices.

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in June 2017 by Zohar Gendler, Stav Tori, Aaron Feldman, and Abraham Yaari, Ark Surgical operates with 11–50 employees. The company has raised a total of $7.11 million across 15 funding rounds and received funding from 2 investors. In April 2025, Ark Surgical secured FDA 510(k) clearance for LapBox® POWER, its dual-wall system for contained morcellation.

Business overview

Ark Surgical is a commercial-stage medical device company specializing in medical devices for women's health. The company develops safer, smarter surgical solutions, including its flagship product, LapBox, a containment system for minimally invasive and robotic gynecologic surgeries. This technology aims to prevent the spread of cancerous or endometrial tissue, addressing a critical need identified by the FDA. Ark Surgical serves the healthcare industry, particularly gynecologic surgeons and hospitals, by optimizing patient safety and helping meet FDA compliance standards for tissue containment.

Strategic signal

In April 2025, Ark Surgical received FDA 510(k) clearance for LapBox® POWER, a significant regulatory milestone. This approval for the world's first dual-wall system for contained morcellation validates the company's innovative approach to enhancing safety in gynecological procedures. This clearance signals to investors a strong market entry potential and regulatory acceptance for Ark Surgical's advanced medical devices, positioning the company for growth in the women's health sector.

Company Intelligence Q&A

What is Ark Surgical's primary focus?
Ark Surgical is a commercial-stage medical device company focused on advancing women’s health through safer, smarter surgical solutions, with two FDA-cleared devices.
When did Ark Surgical receive FDA clearance for LapBox® POWER?
In April 2025, Ark Surgical secured FDA 510(k) clearance for LapBox® POWER, its dual-wall system for contained morcellation.
Which product did Ark Surgical use for the first hysterectomies in the USA?
In November 2023, Ark Surgical performed the first hysterectomies in the USA using its FDA-cleared LapBox for manual morcellation.
What was a key strategic development for Ark Surgical in March 2024?
In March 2024, Ark Surgical secured $1.1 million in funding to advance safer surgical solutions for women's health.
Which company did Ark Surgical acquire?
In November 2018, Ark Surgical acquired SafeSac Medical.